Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | MTOR | P42345 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | HBB | P68871 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.51 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.51 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685844 | 0.88 | MEN1 (0.49) | PAX8LMNATP53GMNNALDH1A1 | |
| SCHEMBL20267951 | 0.86 | ADORA3 (0.52) | LMNATP53DPP4MEN1SLC28A1 | |
| SCHEMBL31685368 | 0.85 | ADORA1 (0.53) | ADORA1SMN1; SMN2 | |
| SCHEMBL31685447 | 0.84 | DNPH1 (0.59) | ADORA1SMN1; SMN2 | |
| SCHEMBL873210 | 0.84 | LMNA (0.58) | LMNATP53GMNNALDH1A1NFKB1 | |
| SCHEMBL1979500 | 0.84 | LMNA (0.58) | LMNATP53GMNNALDH1A1NFKB1 | |
| SCHEMBL30443215 | 0.82 | PAX8 (0.51) | PAX8LMNATP53GMNNALDH1A1 | |
| SCHEMBL19359092 | 0.81 | TYMP (0.65) | PAX8LMNATP53HPGDDPP4 | |
| SCHEMBL18512995 | 0.81 | TYMP (0.65) | PAX8LMNATP53HPGDDPP4 | |
| SCHEMBL23414481 | 0.80 | LMNA (0.59) | PAX8LMNATP53GMNNALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| CN-120158444-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120082543-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-117866948-B | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2023056980-A1 | DESIGN OF SELF-REPLICATING RNA MOLECULES AND APPLICATION THEREOF | 吴可行 | 2023-04-13 | — | — | WO | disclosed |
| CN-107849574-B | UTR for increasing translation efficiency of RNA molecules | 埃泽瑞斯公司 | 2021-11-05 | — | — | CN | disclosed |
| CN-104056668-A | Explosive liquid package and use thereof | UNIV NORTHWESTERN | 2014-09-24 | — | — | CN | disclosed |
| CN-102387966-A | Explosive liquid package and use thereof | UNIV NORTHWESTERN | 2012-03-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | PAX8 1885/4885LMNA 240/4885TP53 557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.